Literature DB >> 21566458

Alzheimer Aβ disrupts the mitotic spindle and directly inhibits mitotic microtubule motors.

Sergiy I Borysov1, Antoneta Granic, Jaya Padmanabhan, Claire E Walczak, Huntington Potter.   

Abstract

Chromosome mis-segregation and aneuploidy are greatly induced in Alzheimer's disease and models thereof by mutant forms of the APP and PS proteins and by their product, the Ab peptide. Here we employ human somatic cells and Xenopus egg extracts to show that Aβ impairs the assembly and maintenance of the mitotic spindle. Mechanistically, these defects result from Aβ's inhibition of mitotic motor kinesins, including Eg5, KIF4A and MCAK. In vitro studies show that oligomeric Aβ directly inhibits recombinant MCAK by a noncompetitive mechanism. In contrast, inhibition of Eg5 and KIF4A is competitive with respect to both ATP and microtubules, indicating that Aβ interferes with their interactions with the microtubules of the mitotic spindle. Consistently, increased levels of polymerized microtubules or of the microtubule stabilizing protein Tau significantly decrease the inhibitory effect of Aβ on Eg5 and KIF4A. Together, these results indicate that by disrupting the interaction between specific kinesins and microtubules and by exerting a direct inhibitory effect on the motor activity, excess Ab deregulates the mechanical forces that govern the spindle and thereby leads to the generation of defective mitotic structures. The resulting defect in neurogenesis can account for the over 30% aneuploid/hyperploid, degeneration-prone neurons observed in Alzheimer disease brain. The finding of mitotic motors including Eg5 in mature post-mitotic neurons implies that their inhibition by Ab may also disrupt neuronal function and plasticity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21566458      PMCID: PMC3356829          DOI: 10.4161/cc.10.9.15478

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  65 in total

Review 1.  The secretases of Alzheimer's disease.

Authors:  Michael S Wolfe
Journal:  Curr Top Dev Biol       Date:  2003       Impact factor: 4.897

Review 2.  The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.

Authors:  John Hardy
Journal:  J Neurochem       Date:  2009-05-18       Impact factor: 5.372

3.  Aneuploidy induction by mitotic arrestants in animal cell systems: possible mechanisms.

Authors:  T C Hsu; K L Satya-Prakash
Journal:  Basic Life Sci       Date:  1985

4.  Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease.

Authors:  L N Geller; H Potter
Journal:  Neurobiol Dis       Date:  1999-06       Impact factor: 5.996

5.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis.

Authors:  Juliette D Godin; Kelly Colombo; Maria Molina-Calavita; Guy Keryer; Diana Zala; Bénédicte C Charrin; Paula Dietrich; Marie-Laure Volvert; François Guillemot; Ioannis Dragatsis; Yohanns Bellaiche; Frédéric Saudou; Laurent Nguyen; Sandrine Humbert
Journal:  Neuron       Date:  2010-08-12       Impact factor: 17.173

7.  Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy.

Authors:  Debrah I Boeras; Antoneta Granic; Jaya Padmanabhan; Nichole C Crespo; Amyn M Rojiani; Huntington Potter
Journal:  Neurobiol Aging       Date:  2006-12-13       Impact factor: 4.673

8.  Microtubular interactions of presenilin direct kinesis of Abeta peptide and its precursors.

Authors:  Nikolaos Tezapsidis; Patricia A Merz; George Merz; Heni Hong
Journal:  FASEB J       Date:  2003-05-08       Impact factor: 5.191

9.  Chromosome studies of patients with Alzheimer disease.

Authors:  P S Moorhead; A Heyman
Journal:  Am J Med Genet       Date:  1983-03

10.  Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta.

Authors:  G Pigino; G Morfini; Y Atagi; A Deshpande; C Yu; L Jungbauer; M LaDu; J Busciglio; S Brady
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

View more
  26 in total

1.  Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function.

Authors:  Csilla Ari; Sergiy I Borysov; Jiashin Wu; Jaya Padmanabhan; Huntington Potter
Journal:  Neurobiol Aging       Date:  2014-02-10       Impact factor: 4.673

2.  Kinesin light chain-1 variant E disrupts axonal transport and Aβ generation in Alzheimer's disease (comment on DOI 10.1002/bies.201400131).

Authors:  Huntington Potter
Journal:  Bioessays       Date:  2015-01-12       Impact factor: 4.345

3.  Down syndrome and Alzheimer's disease: Common pathways, common goals.

Authors:  Dean Hartley; Thomas Blumenthal; Maria Carrillo; Gilbert DiPaolo; Lucille Esralew; Katheleen Gardiner; Ann-Charlotte Granholm; Khalid Iqbal; Michael Krams; Cynthia Lemere; Ira Lott; William Mobley; Seth Ness; Ralph Nixon; Huntington Potter; Roger Reeves; Marwan Sabbagh; Wayne Silverman; Benjamin Tycko; Michelle Whitten; Thomas Wisniewski
Journal:  Alzheimers Dement       Date:  2014-12-12       Impact factor: 21.566

4.  KIF2C regulates synaptic plasticity and cognition in mice through dynamic microtubule depolymerization.

Authors:  Rui Zheng; Yonglan Du; Xintai Wang; Tailin Liao; Zhe Zhang; Na Wang; Xiumao Li; Ying Shen; Lei Shi; Jianhong Luo; Jun Xia; Ziyi Wang; Junyu Xu
Journal:  Elife       Date:  2022-02-09       Impact factor: 8.140

5.  The Gαq/phospholipase Cβ signaling system represses tau aggregation.

Authors:  Osama Garwain; V Siddartha Yerramilli; Kate Romero; Suzanne Scarlata
Journal:  Cell Signal       Date:  2020-04-01       Impact factor: 4.315

6.  Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss.

Authors:  Ronald K Freund; Emily S Gibson; Huntington Potter; Mark L Dell'Acqua
Journal:  Mol Pharmacol       Date:  2016-03-08       Impact factor: 4.436

Review 7.  Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.

Authors:  Huntington Potter; Antoneta Granic; Julbert Caneus
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 8.  Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis.

Authors:  Sanghamitra Bandyopadhyay; Jack T Rogers
Journal:  Biochem Pharmacol       Date:  2014-02-07       Impact factor: 5.858

Review 9.  The genomically mosaic brain: aneuploidy and more in neural diversity and disease.

Authors:  Diane M Bushman; Jerold Chun
Journal:  Semin Cell Dev Biol       Date:  2013-03-04       Impact factor: 7.727

10.  Aβ 1-40 enhances the proliferation of human diploid fibroblasts.

Authors:  Lindsey Theda; Michelle K Drews; Galynn Zitnik; Junko Oshima; George M Martin
Journal:  Neurobiol Aging       Date:  2015-11-02       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.